Skip to main content
logo
Arbutus Biopharma Corporation (ABUS)
NASDAQ: ABUS · Real-Time Price · USD
4.220
-0.070 (-1.63%)
Oct 16, 2026, 4:00 PM EDT - Market closed

Arbutus Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
835925620419365526
Market Cap Growth
-2.51%49.29%47.80%15.00%-30.72%74.57%
Enterprise Value
746836496285189556
Last Close Price
4.224.813.272.502.333.89

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-236.87236.87236.87236.87236.87
PS Ratio
4.5965.69100.4123.119.3447.89
PB Ratio
3.2212.086.363.952.663.11
P/TBV Ratio
3.2312.086.363.952.663.11

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
4.1059.3680.3215.694.8550.59

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.060.060.080.090.11
Net Debt / Equity Ratio
-0.34-1.14-1.20-1.17-1.25-1.02
Net Debt / EBITDA Ratio
-0.603.271.701.612.782.46
Net Debt / FCF Ratio
3.612.201.791.424.792.52
Asset Turnover
0.960.120.050.110.200.06
Quick Ratio
81.0815.528.035.714.5113.92
Current Ratio
81.4215.738.155.874.6014.32
Return on Equity (ROE)
89.58%-38.52%-68.76%-59.99%-45.35%-56.19%
Return on Assets (ROA)
48.84%-14.94%-31.68%-28.70%-19.76%-26.22%
Return on Capital Employed (ROCE)
54.50%-30.50%-60.30%-64.00%-38.90%-37.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
18.33%-3.62%-11.28%-17.38%-19.05%-14.49%
FCF Yield
-2.95%-4.29%-10.50%-20.74%-9.84%-12.99%
Buyback Yield / Dilution
-2.21%-3.23%-11.84%-9.95%-42.07%-40.10%
SEC Filings: 10-K · 10-Q